Gilead Sciences (GILD) Tops Q1 EPS by 48c, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Gilead Sciences (GILD) 'Crushed' the Quarter, Piper Jaffray Says; Remains Top Large-Cap Biotech Pick
May 1, 2015 7:10 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and lifted his price target on Gilead Sciences (NASDAQ: GILD) to $120.00 (from $116.00) after the company "crushed" the quarter and raised its outlook.
Schimmer commented, "GILD hosted the 1Q earnings call after the... More
Gilead Sciences (GILD) Bullish Stance Reiterated at BMO Capital Amid 'Strong' Q1
May 1, 2015 7:00 AM EDTBMO Capital analyst Jim Birchenough reiterated an Outperform rating and $159 price target on Gilead Sciences (NASDAQ: GILD) following "strong" Q1 results after the close with room to expand in HCV.
Birchenough commented, "We are maintaining our Outperform rating on the shares of GILD... More
Gilead Sciences (GILD) Bullish Stance Reiterated at Baird on 'Beat and Raise' Q1
May 1, 2015 6:42 AM EDTBaird analyst Brian Skorney reiterated an Outperform rating and $126 price target on Gilead Sciences (NASDAQ: GILD) following 'beat and raise' Q1.
Skorney commented, "A sizeable beat should be enough to support the stock and perhaps stop the sector slide. We expect... More
Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.7% Yield
April 30, 2015 5:21 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.43 per share, or $1.72 annualized.
The dividend will be payable on June 29, 2015, to stockholders of record on June 16, 2015, with an ex-dividend date of June 12, 2015.
The annual yield on the dividend is 1.7... More
